BEIJING, Sept 24 (Reuters) - China's Sinovac Biotech expects to begin analysing final-stage human trial data on its coronavirus vaccine candidate this year to decide whether it is effective enough to ...
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, ...
BEIJING--(BUSINESS WIRE)-- Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel ...
Sinovac Biotech Ltd. (NASDAQ: SVA) (“ SINOVAC ” or the “ Company ”), a leading provider of biopharmaceutical products in China, today provided an update on the Antigua High Court’s interlocutory order ...
(RTTNews) - Sinovac Biotech Ltd. (SVA) announced an update on the Antigua High Court's interlocutory order regarding the Company's board composition and corporate actions pending trial. The Company ...
The World Health Organization granted emergency authorisation to a vaccine co-developed by India’s medical research agency and local manufacturer Bharat Biotech International, adding another tool to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results